“Generic drug-making is a fast-track business”: Sandoz trademark head reveals approach to IP management
For the latest in World Trademark Review’s series of interviews with WTR 300-listed corporate counsel, we met up with David Lossignol, INTA’s president elect and global head of trademarks for Sandoz. Providing a fascinating insight into his work, he explained how he overcomes the challenges of managing pharmaceutical brand rights across many jurisdictions, addressed the growing threat of brand restrictions and emphasised the importance of team work in legal practice as well as within professional organisations.
Want to read more?
Register to access two of our subscriber only articles per month
Subscribe for unlimited access to articles, in-depth analysis and research from the World Trademark Review experts
What our customers are saying
World Trademark Review, and particularly the WTR 1000, are always very useful sources for obtaining impressions and detailed information about foreign colleagues, law firms and jurisdictions. Our whole trademark team benefits from articles published in World Trademark Review.
Christian R Thomas
Attorney at law, legal and trademark department
KUHNEN & WACKER Intellectual Property Law Firm
Subscribe to World Trademark Review to receive access to the full range of trademark intelligence, insight, and case law, as well as our guides, rankings and daily market insight delivered to your inbox.
Register for more free content
- Read more World Trademark Review blogs and articles
- Receive the editor's weekly review by email